STX
53
3
TXN
43
-3
V
56
2
FLR
60
4
THC
67
2
APH
65
4
PCG
77
3
HIG
54
2
PDCO
41
3
MKC
56
3
IVZ
52
6
LUV
40
2
AEE
55
5
FDX
41
11
UNP
48
6
DFS
60
4
BLK
69
3
ESS
56
5
VRTX
62
10
ROK
42
4
STX
53
3
TXN
43
-3
V
56
2
FLR
60
4
THC
67
2
APH
65
4
PCG
77
3
HIG
54
2
PDCO
41
3
MKC
56
3
IVZ
52
6
LUV
40
2
AEE
55
5
FDX
41
11
UNP
48
6
DFS
60
4
BLK
69
3
ESS
56
5
VRTX
62
10
ROK
42
4
Financhill
Back

Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
83

RYTM
Rhythm Pharmaceuticals

Last Price:
56.20
Seasonality Move:
9.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Rhythm Pharmaceuticals Price Quote

$56.20
-0.05 (6.06%)
(Updated: November 6, 2024 at 5:25 AM ET)

Rhythm Pharmaceuticals Key Stats

Buy
83
Rhythm Pharmaceuticals (RYTM) is a Buy
Day range:
$52.46 - $56.58
52-week range:
$23.83 - $56.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.92
P/B ratio:
87.41%
Volume:
792.2K
Avg. volume:
325.4K
1-year change:
108.57%
Market cap:
$3.4B
Revenue:
$77.4M
EPS:
$-4.36

How Much Does Rhythm Pharmaceuticals Make?

Is Rhythm Pharmaceuticals Growing As A Company?

Rhythm Pharmaceuticals Stock Price Performance

What Is Rhythm Pharmaceuticals 52-Week High & Low?

Rhythm Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rhythm Pharmaceuticals?

Is Rhythm Pharmaceuticals Cash Flow Positive?

  • What Is RYTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$128.5M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $225.9M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$50.8M

Rhythm Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RYTM return on invested capital is -164.07%
  • What Is Rhythm Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -79.22%
  • What Is RYTM Return On Equity?
    ROE is a measure of profitability and is -164.07%

Rhythm Pharmaceuticals Earnings Date & Stock Price

Rhythm Pharmaceuticals Competitors

Rhythm Pharmaceuticals Dividend Yield

Rhythm Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 23.79%
Revenue: 51.28% 1%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 60.64
Upside from Last Price: 7.8%

Major Shareholders

  • How many RYTM shares are owned by institutional investors?
    105.7M RYTM shares are owned by institutional investors
  • How many RYTM shares are owned by insiders?
    1.1M RYTM shares are owned by insiders